ગુજરાતી
English
Tag: આરોગ્ય અને પરિવાર કલ્યાણ મંત્રાલય
DCGI approves Phase II+III trials of Oxford University vaccine by Seru...
India’s Case Fatality Rate (CFR) further drops to 2.11% , Total Recoveries more than 11.8 lakh
Delhi, 03 AUG 2020
The Drugs Controller General of India (DCGI) has given approval to Serum Institute of India, Pune to conduct Phase II+III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD) in India. This will hasten the d...